Literature DB >> 2427557

Epidermal and dermal distribution of a myelomonocytic antigen (L1) shared by epithelial cells in various inflammatory skin diseases.

T O Gabrielsen, I Dale, P Brandtzaeg, P S Hoel, M K Fagerhol, T E Larsen, P O Thune.   

Abstract

The L1 antigen is a major cytosol component of human granulocytes that may also be expressed by macrophages and epithelial cells. Its epidermal and dermal occurrence was investigated in formalin-fixed routine biopsy material from eleven different inflammatory skin disorders. Localization was performed with a rabbit antiserum to L1 applied in an unlabeled antibody peroxidase-antiperoxidase method. L1 antigen was not found in normal skin except in epithelial cells of pilosebaceous units. However, epidermal L1 antigen was demonstrated in every biopsy specimen from lupus erythematosus, lichen planus, dermatitis herpetiformis, and atopic dermatitis, whereas granuloma annulare test results were usually negative. The occurrence of dermal L1 antigen depended on the composition of the inflammatory infiltrate; specimens rich in neutrophilic granulocytes (e.g., dermatitis herpetiformis) were particularly strongly stained. Extracellular dermal staining was also seen, especially in areas adjacent to accumulation of positive leukocytes. The varying epidermal occurrence of L1 antigen in skin diseases probably signified different degrees of proliferative activity of the epithelial cells and could apparently not be ascribed to uptake from the dermis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427557     DOI: 10.1016/s0190-9622(86)70152-7

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  15 in total

1.  Epidermal expression of the calcium binding surface antigen 27E10 in inflammatory skin diseases.

Authors:  M Kunz; J Roth; C Sorg; G Kolde
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

2.  ANTI-INFECTIVE PROTECTIVE PROPERTIES OF S100 CALGRANULINS.

Authors:  Kenneth Hsu; Chantrakorn Champaiboon; Brian D Guenther; Brent S Sorenson; Ali Khammanivong; Karen F Ross; Carolyn L Geczy; Mark C Herzberg
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2009-12-04

3.  Nomenclature for proteins: is calprotectin a proper name for the elusive myelomonocytic protein?

Authors:  M K Fagerhol
Journal:  Clin Mol Pathol       Date:  1996-04

Review 4.  Functional and clinical aspects of the myelomonocyte protein calprotectin.

Authors:  B Johne; M K Fagerhol; T Lyberg; H Prydz; P Brandtzaeg; C F Naess-Andresen; I Dale
Journal:  Mol Pathol       Date:  1997-06

5.  Mac 387 antibody and detection of formalin resistant myelomonocytic L1 antigen.

Authors:  P Brandtzaeg; D B Jones; D J Flavell; M K Fagerhol
Journal:  J Clin Pathol       Date:  1988-09       Impact factor: 3.411

6.  S100A8 triggers oxidation-sensitive repulsion of neutrophils.

Authors:  H Y Sroussi; J Berline; P Dazin; P Green; J M Palefsky
Journal:  J Dent Res       Date:  2006-09       Impact factor: 6.116

Review 7.  Calprotectin in rheumatic diseases.

Authors:  Francesca Ometto; Lara Friso; Davide Astorri; Costantino Botsios; Bernd Raffeiner; Leonardo Punzi; Andrea Doria
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-01

8.  Changes in gene expression in human meibomian gland dysfunction.

Authors:  Shaohui Liu; Stephen M Richards; Kristine Lo; Mark Hatton; Aaron Fay; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-25       Impact factor: 4.799

9.  Myeloid cell function in MRP-14 (S100A9) null mice.

Authors:  Josie A R Hobbs; Richard May; Kiki Tanousis; Eileen McNeill; Margaret Mathies; Christoffer Gebhardt; Robert Henderson; Matthew J Robinson; Nancy Hogg
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

Review 10.  Novel insights into the role of S100A8/A9 in skin biology.

Authors:  Claus Kerkhoff; Andreas Voss; Thomas E Scholzen; Michelle M Averill; Kurt S Zänker; Karin E Bornfeldt
Journal:  Exp Dermatol       Date:  2012-08-09       Impact factor: 3.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.